Q4 2022

Welcome to the Q4 edition of Global Health & Pharma Magazine 2022, providing you with all of the latest news and features from across the healthcare and pharmaceutical landscape.

There’s no denying how the health and pharma industry is one of the most innovative in the world, having over the past century played such a crucial role in the development of new and improved medicines to prevent and treat diseases, as well as enhance quality of life for so many. This unique, thriving industry continues to revolutionise healthcare by helping to tackle unmet medical needs.

An example of a company doing just this is our cover feature, Elucent Medical, who deliver ground-breaking solutions that enable surgeons to provide individualised patient care, no matter how simple or complex, with great efficiency and effectiveness. It is an extraordinary company that continues to evolve and redefine the standards of care to improve patient lives, and we are delighted to be giving you an insight into its work.

Overall, we are proud to bestow our awards upon a myriad of cutting-edge businesses as they end 2022 on a high. All of us at GHP wish you a restful and reflective festive season and a prosperous new year. We look forward to welcoming you back again for the Q1 issue.

Q3 2022

Welcome to the Q3 edition of Global Health & Pharma Magazine 2022, providing you with all of the latest news and features from across the healthcare and pharmaceutical landscape.

Global health and pharmaceuticals is an extremely important part of our world. As we continue to grow and improve, we are quickly advancing scientifically. The only difficulty is that industries need to keep up with these changes. By using the most intricate, pioneering, relevant, and cutting-edge technologies and methods, we are able to focus in on making the world a healthier – and therefore happier – place for all.

This issue showcases a selection of businesses that work with clinical trials, AI technology, and much more to provide excellent healthcare services. With the population growing, there is a bigger need to evolve. In this way, it is obvious that these companies are contributing to this new age of scientific development for the greatest outcome in healthcare services. With smart solutions and helpful equipment, anything is possible.

We are proud to present these ground-breaking businesses as they win a plethora of enviable awards. All of us at GHP hope you have a tremendous quarter ahead. We look forward to welcoming you back again for Q4 this year.

Q2 2022

Welcome to the Q2 edition of Global Health & Pharma Magazine 2022, providing you with all of the latest news and features from across the healthcare and pharmaceutical landscape.

We are always in need of scientific developments. With a plethora of diseases, conditions, and medical issues in general, we require the rapid progress of remedies and cures. From medicine to devices, the most important thing is that we become more vigilant and resilient with our inventions, preventions, and ways of living our lives.

In this issue we explore some practices, firms, and companies that are using their sheer intellect and highly professional attitude to change the medical sphere. From innovative dental care to intricate surgery, medical device development to exceptional biotechnology, and much more, this issue of GHP is looking at a variety of businesses that are altering the way we see healthcare and medicine as a whole.

All of us at GHP wish you very prosperous and fulfilling times ahead and we look forward to delivering Q3 to you soon.

Q1 2022

Welcome to the Q1 edition of Global Health & Pharma Magazine 2022, providing you with all of the latest news and features from across the healthcare and pharmaceutical landscape.

With tensions continuing to build around the globe, we can see an influx of individuals and businesses that promote togetherness. Here we can see the building blocks to a better future in health and research to overcome some of life’s greatest challenges.

It is this togetherness that ensures safe spaces for people everywhere – mentally, physically, and emotionally. We experience these medical developments in a way that changes our perception of good health as well as our relationships with our bodies.

In this issue we see the present and future of testing, holistic wellness, luxury training facilities, nutritional ingredient solutions, and much more. With skilled and revolutionary clinics that are leaders in their industry; we open, continue, and finish strong throughout this entire issue.

These excellent success stories show us more beneficial treatments and health services than ever before. We have been in touch with many companies, across an assortment of sectors, that are researching and enforcing new ways of curing, testing, and supporting people all over the world.

For example, The Whiteley Clinic’s treatments in the field of phlebology has propelled it to a point of great success. With its blood research abilities and passion, it has been changing the course of healthcare.

As spring swiftly approaches us, we at GHP wish you a very happy March. We look forward to seeing you again for Q2.

Q4 2021

Welcome to the 2021 Q4 edition of Global Health & Pharma Magazine, providing you with all the latest news and features from across the healthcare and pharmaceutical landscape.

The last couple of years have witnessed a wide variety of businesses, across multiple industries, flourish and thrive even in the face of adversity. However, here we can see a selection of particularly innovative and focused businesses that have astonishingly excelled throughout the global pandemic.

For instance, our cover company Smart Blood Analytics have introduced two fine products that have altered the way we diagnose illnesses. This experienced Swiss business harnesses the power of Artificial Intelligence to detect any current or future defects within the blood. This is an invaluable service that can ultimately conquer the late diagnosis of serious illness and disease. With developments like this we can look towards the future with confidence.

Join us as we delve deeper into many other successful business stories that have not only stood the test of time, but that have grown exponentially throughout some of the darkest days. As usual, we hope you enjoy this issue and we look forward to seeing you again for Q1 2022.

Q3 2021

Welcome to the 2021 Q3 edition of Global Health & Pharma Magazine, providing you with all the latest news and features from across the healthcare and pharmaceutical landscape.

As we come towards the final quarter of a second year shaped by a global pandemic, we might be excused for thinking only on the exceptional work around Covid-19 when reflecting on the successes achieved by the healthcare and pharmaceutical industries this year. However, over the last quarter, the global companies within these vital sectors have remained just as – if not more – busy with endeavours outside the pandemic as well.

From the development of lasers and their expanding capabilities being championed by our cover company for this month, Erchonia Lasers, to the ground-breaking personalisation technology within breast cancer treatment being developed by DCISionRT, to the many other stories of exceptional and transformational work exhibited in this issue of GHP Magazine, it is clear that the global health and pharmaceutical industry has a lot to be proud of this quarter.

Thus, we invite you to dive in and discover more about these fantastic companies and their life-changing work – whether it be in aesthetic treatments or surgical procedures, pharmaceutical innovations or the enhanced services. We hope you enjoy this issue of GHP Magazine, and wish you safe and well until we meet again in the Q4 edition.

Q2 2021

Welcome to the 2021 Q2 edition of Global Health & Pharma Magazine, providing you with all the latest news and features from across the healthcare and pharmaceutical landscape.

While the last eighteen months have seen all industries demonstrating resilience and versatility in a period defined by adversity, few have matched the exceptional work of the global healthcare and pharmaceutical industries. These impressive feats are by no means limited to successful vaccine programme rollouts or treatment of Covid-19 cases – as individuals have become more aware of the importance of caring for our general physical and mental wellbeing during the pandemic, organisations across the industry have seen demand for their products and services soar.

That is certainly the case for the companies included in this quarter’s edition of GHP, including our cover company, BioMin Technologies, a leading researcher into dental sensitivity and developer of sensitivity relief and prevention products. We find out how this London-based start-up has grown since 2015 and plans to build on the momentum generated in online sales during the pandemic to see further growth that facilitates exciting advanced research into dental sensitivities.

Join us as we explore many of the other success stories to come out of this vibrant and valued industry over the past few months. Until the next issue of GHP, we wish you all the best for the months ahead.

GHP Q1 2021 Cover

Q1 2021

Welcome to the 2021 Q1 edition of Global Health & Pharma Magazine, providing you with all the latest news and features from across the healthcare and pharmaceutical landscape.

Whilst 2020 may have proven to be a very difficult year for many, the healthcare and pharmaceutical industry was certainly pushed to its limits. Yet, just over twelve months on from the start of the pandemic and national lockdowns, there is sign of reprieve and hope that life can begin again. The rollout of vaccines in the fight against COVID-19 has proven to be a success, healthcare and pharmaceutical staff have given everything to help others, and the world is slowly but surely showing signs of returning to normal.

Speaking of returning to normal, many people will be yearning to get back to their hairdresser or barber and see to it that their hair is restored to its former glory. For those who have struggled with hair loss, be it genetic or simply pulling it out at the thought of an extended lockdown , the work of Juvida Clinics represents the same kind of hope for people who want their hair back. Juvida Clinics may not be able to bring back the last twelve months, but it can inspire youthfulness and life in its clients, helping them get ready for a return to life as normal with friends and family.

There is plenty more success stories such as this one to unpack within these pages, with each company featured delivering its own success through insightful knowledge and fantastic innovation in abundance. For now, we hope that you are staying safe and enjoy reading this latest issue of Global Health & Pharma.

Q4 2020

Welcome to the Q4 edition of Global Health & Pharma Magazine, providing you with all of the latest news and features from across the healthcare and pharmaceutical landscape.

These past twelve months have certainly been a turbulent time, especially for those working within healthcare and pharmaceutical industry. Whilst some have had to shut their doors due to safety concerns, others have found great success.

For example, Fortress Diagnostics who develops, manufactures and supports an extensive portfolio of clinical diagnostic tests had to alter the way in which they shipped orders to ensure all customer needs were met. The result? The number of partners increased, plus their quality is much higher than it was previously.

This success story is just one of the many featured within the pages of this packed and insightful issue of Global Health & Pharma. For now, we hope that you stay safe and have a Merry Christmas and a wonderful New Year, and we look forward to welcoming you back in 2021.

Q3 2020

Welcome to the Q3 issue of Global Health & Pharma Magazine – your source for all of the latest news and features from across the healthcare and pharmaceutical landscape.

It is safe to say these past few months have tested the capabilities of many, especially those working in healthcare and pharmaceutical industries. For many companies operating within such a dynamic and ever-changing industries such as healthcare, the pandemic has created a number of opportunities that they could have never predicted.

In this issue, we take a closer look at the firms who have been fortunate to expand their business during these unprecedented times. From a light sensor designed for seniors dealing with rehabilitation and readjusting to normal life during the COVID-19 pandemic, to a dental practice which is increasing its brand awareness expanding the business whilst diluting the excellence of its existing services. We cover a selection of businesses who have done all they can to remain operational during lockdown and how they are coping post lockdown too.

For now, the team here at Global Health & Pharma hope you are doing well and staying safe, and look forward to hearing from you soon.

Q2 2020

Welcome to the Q2 issue of the Global Health & Pharma Magazine – your source for the latest news and features from across the healthcare and pharmaceutical industries.  

It’s been a strange time, though (maybe it’s the eternal optimist in me) it looks like things are changing. Tentatively, slowly, we’re seeing a shift towards ‘normal’, whatever form ‘normal’ might take going forwards. Where the world has seemed to slow to a snail’s pace, the healthcare and pharmaceutical industries have moved forward relentlessly. This dichotomy has never been more obvious than in the last few months. Healthcare never stops. It can’t – it’s fundamental. It’s a cornerstone to society. The entire industry, and its supplementary fields, keep the world moving. We’ve seen that now with perfect clarity.

With this issue, we want to showcase a selection of the businesses that don’t stop. That keep moving, onwards, further, higher.

In the meantime, I hope you all have a wonderful few months ahead. Stay safe and well.

Q1 2020


GHP Q1 2020 - Cover

Welcome to the Q1 2020 issue of Global Health & Pharma Magazine – your source for the latest news and features from across the healthcare and pharmaceutical industries.

I don’t think any of us expected to be writing automatic replies that spoke of “pandemics”, and its profound impact on day to day affairs. Yet, here we are.

It’s all a bit surreal. Anxiety and unease are high, and the best method for coping right now is to adopt the rather timeless approach of “keeping calm and carrying on”.

Naturally, while there are mentions of COVID-19 and the Coronavirus in this issue, we’ve tried to keep it to a minimum. After all, while it’s a good idea to stay informed and in the know, there’s such a thing as too much information. It’s OK – in fact, highly encouraged – to take a break. Do something fun. Something you enjoy. Take a moment for yourself.

Whether you’re self-isolating at home, on the frontlines in hospitals and surgeries across the world, or making sure your nations carry on, GHP News hopes you all stay safe and well. This too shall pass.